As seen on:
As seen on:














Latest Articles
The STI is above 4,200. Here’s what you need to know before the next move.
SGX Added Two More Hong Kong Singapore Depository Receipts: Here’s What You Need to Know
Investors now have an even larger slate of SDRs to choose from, covering a wide range of industries.
The STI is at new highs, but can it last? Watch our webinar recording to get a strategic edge and navigate the opportunities and risks ahead.
We look at the recent news swirling around the telco space to identify which company benefits or loses out.
5 Singapore Companies Made it to Forbes Asia “Best Under a Billion” List: Should You Add Them to Your Buy Watchlist?
These five companies displayed attractive attributes that enabled them to qualify for this prestigious list.
Despite the bombast and bluster, the Trump administration has only delivered an average performance. After…
Popular
You’ll be amazed at how much wealth you would have created just by holding on to Sheng Siong’s shares over the years.
Does the retail REIT have what it takes to continue raising its distributions?
Here’s how Singapore REITs can earn you a solid yield of 5% or higher and help you to build up a stream of dividend income.
Rising oil prices could fuel gains for these 3 Singapore-listed companies.
Stocks
Worried that the market has peaked? Here are three REITs still offering dividend yields above 6%.
These four Singapore REITs rank high on reliability and dependability.
Top Stock Market Highlights: Alibaba Exits SingPost, MetaOptics IPO Surges 25%, DBS Hits Record S$53
DBS Bank broke S$53 for the first time this week, pushing the STI to a record 4,367 points. Alibaba exited SingPost with a 151.3 million share sale, while MetaOptics surged 25% on its Catalist debut. SGX also announced plans for a new index tracking mid-cap stocks beyond the STI’s 30 components.
With President Trump unleashing a wave of tariffs across more than 180 countries, here’s how you can navigate the choppy stock market.
Getting Started
As we head into a new year, here are five ways you can enhance your portfolio returns.
Will technology stocks remain relevant in the brave new world?
The world faces a different kind of problem aside from the pandemic, but one that can be tackled with pharmaceuticals.
With a potential rocky and unsteady recovery post-COVID-19, here’s how you can locate stocks that will do well.


















